Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01375 |
| Species: | Homo sapiens |
| Position : | chr17:47970000-47975000 |
| Year: | 2024 |
| Title: | CDK5RAP3 is a novel super-enhancer-driven gene activated by master TFs and regulates ER-Phagy in neuroblastoma |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | neuroblastoma |
| PMID: | 38636893 |
| MONDO: | MONDO:0005070 |
| Tissue: | Adrenal gland |
| Tissue Ontology ID: | UBERON:0002369 |
| Cell Source: | SK-N-BE(2) |
| CVCL ID: | CVCL_0528 |
| Cell Type: | neuroblastoma cell |
| Cell Ontology ID: | CL:0000031 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Chromatin interaction assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, Hi-C, CUT&Tag, RNA-seq |
| Low Throughput Method: | Luciferase Reporter Assay, 3C-RT-qPCR, CUT&RUN-RT-qPCR, CRISPRi, RT-RT-qPCR, Western blot |
| Target gene : | CDK5RAP3 |
| TF name : | MEIS2; HAND2 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01376 | chr17:47940000-48020000 | Adrenal gland | neuroblastoma cell | neuroblastoma |